Tech Center 1600 • Art Units: 1644 1671
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18261983 | BONE-SPECIFIC DELIVERY OF POLYPEPTIDES | Non-Final OA | Baylor College of Medicine |
| 18034621 | CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL EXPRESSING CXCL12 RECEPTOR | Non-Final OA | RIKEN |
| 18459866 | METHOD FOR IMPROVING WOUND HEALING | Non-Final OA | NATIONAL YANG MING CHIAO TUNG UNIVERSITY |
| 18351515 | BINDING MOLECULES FOR THE TREATMENT OF CANCER | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18368647 | METHODS OF PERSONALIZED PRECONDITIONING FOR CELL THERAPY | Non-Final OA | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| 18491733 | ANTIVIRALS AGAINST MEASLES VIRUS | Non-Final OA | INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE |
| 18365950 | CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR GPRC5D AND BCMA | Non-Final OA | Juno Therapeutics, Inc. |
| 18285459 | ANTI-CNTN4 ANTIBODY AND USE THEREOF | Non-Final OA | GENOME AND COMPANY |
| 18460246 | TREATMENT OF HERPES SIMPLEX VIRUS INFECTION | Non-Final OA | United BioPharma, Inc. |
| 18275481 | METHODS FOR PREVENTING ORAL SENSITIZATION | Non-Final OA | MY-OR DIAGNOSTICS LTD. |
| 18360742 | USE OF CYP4V2 AND RDCVF IN THE MANUFACTURE OF MEDICAMENT | Non-Final OA | CHIGENOVO CO., LTD. |
| 18273661 | CHIMERIC ANTIGEN RECEPTOR (CAR) CONSTRUCTS AND NK CELLS EXPRESSING CAR CONSTRUCTS | Non-Final OA | CYTOCARES (SHANGHAI) INC. |
| 18265591 | Anti-Human MSLN Antibody And Application Thereof | Non-Final OA | NANJING ZAIMING PHARMACEUTICAL CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy